DK1562918T3 - Substituerede benzoxazinoner og anvendelser deraf - Google Patents
Substituerede benzoxazinoner og anvendelser derafInfo
- Publication number
- DK1562918T3 DK1562918T3 DK03789002T DK03789002T DK1562918T3 DK 1562918 T3 DK1562918 T3 DK 1562918T3 DK 03789002 T DK03789002 T DK 03789002T DK 03789002 T DK03789002 T DK 03789002T DK 1562918 T3 DK1562918 T3 DK 1562918T3
- Authority
- DK
- Denmark
- Prior art keywords
- substituted benzoxazinones
- benzoxazinones
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
- C07D291/08—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42494602P | 2002-11-08 | 2002-11-08 | |
PCT/EP2003/012278 WO2004041792A1 (en) | 2002-11-08 | 2003-11-04 | Substituted benzoxazinones and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1562918T3 true DK1562918T3 (da) | 2008-05-05 |
Family
ID=32312902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03789002T DK1562918T3 (da) | 2002-11-08 | 2003-11-04 | Substituerede benzoxazinoner og anvendelser deraf |
Country Status (28)
Country | Link |
---|---|
US (1) | US7141562B2 (ko) |
EP (1) | EP1562918B1 (ko) |
JP (1) | JP4401297B2 (ko) |
KR (1) | KR100683361B1 (ko) |
CN (1) | CN100390157C (ko) |
AR (1) | AR042002A1 (ko) |
AT (1) | ATE384054T1 (ko) |
AU (1) | AU2003293653B2 (ko) |
BR (1) | BR0315302A (ko) |
CA (1) | CA2505334A1 (ko) |
DE (1) | DE60318733T2 (ko) |
DK (1) | DK1562918T3 (ko) |
ES (1) | ES2298609T3 (ko) |
GT (1) | GT200300241A (ko) |
HR (1) | HRP20050390A2 (ko) |
IL (1) | IL168343A (ko) |
MX (1) | MXPA05004758A (ko) |
MY (1) | MY136824A (ko) |
NO (1) | NO20052074L (ko) |
NZ (1) | NZ539508A (ko) |
PA (1) | PA8587501A1 (ko) |
PE (1) | PE20040828A1 (ko) |
PL (1) | PL377770A1 (ko) |
PT (1) | PT1562918E (ko) |
RU (1) | RU2328490C2 (ko) |
TW (1) | TWI285639B (ko) |
WO (1) | WO2004041792A1 (ko) |
ZA (1) | ZA200503248B (ko) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003007956A1 (en) * | 2001-07-20 | 2003-01-30 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder |
JP4455064B2 (ja) | 2002-03-27 | 2010-04-21 | グラクソ グループ リミテッド | キノリン誘導体および5−ht6リガンドとしてのその使用 |
ATE313532T1 (de) | 2003-07-22 | 2006-01-15 | Arena Pharm Inc | Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen |
AU2004299201B2 (en) * | 2003-12-09 | 2009-12-03 | F. Hoffmann-La Roche Ag | Benzoxazine derivatives and uses thereof |
US7713954B2 (en) * | 2004-09-30 | 2010-05-11 | Roche Palo Alto Llc | Compositions and methods for treating cognitive disorders |
RU2420318C2 (ru) * | 2004-09-30 | 2011-06-10 | Ф.Хоффманн-Ля Рош Аг | Композиции и способы для лечения когнитивных расстройств |
CN101263136A (zh) | 2005-07-13 | 2008-09-10 | 弗·哈夫曼-拉罗切有限公司 | 作为5-ht6、5-ht24的苯并咪唑衍生物 |
WO2007032572A1 (en) * | 2005-09-15 | 2007-03-22 | Korea Reserach Institute Of Chemical Technology | N-substituted-1h-quinoline-2, 4-diones, preparation method thereof, and pharmaceutical composition containing the same |
CA2658959A1 (en) * | 2006-06-23 | 2007-12-27 | Laboratorios Del Dr. Esteve, S.A. | Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity |
WO2009074607A1 (en) | 2007-12-12 | 2009-06-18 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
ITMI20131782A1 (it) * | 2013-10-25 | 2015-04-26 | Dipharma Francis Srl | Procedimento per la preparazione di un agonista della trombopoietina |
WO2016201373A1 (en) | 2015-06-12 | 2016-12-15 | Axovant Sciences Ltd. | Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of rem sleep behavior disorder |
CN108472285A (zh) | 2015-07-15 | 2018-08-31 | 阿速万科学有限责任公司 | 用于预防和治疗与神经退行性疾病相关联的幻觉的二芳基和芳基杂芳基脲衍生物 |
RU2624978C2 (ru) * | 2015-07-27 | 2017-07-11 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежский государственный медицинский университет им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации | Способ лечения умеренного когнитивного снижения |
SI3649124T1 (sl) * | 2017-08-07 | 2021-09-30 | Suven Life Sciences Limited | Fluoropiperidinske spojine kot čisti 5-HT6 receptor antagonisti |
CN111559990B (zh) * | 2020-05-29 | 2021-03-09 | 四川大学华西医院 | 一种小分子噁噻嗪类衍生物及其应用 |
CN112047898A (zh) * | 2020-10-14 | 2020-12-08 | 兰州大学 | 一种苯并[c][1,2]噁嗪骨架类新化合物及其制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0189612B1 (en) | 1984-12-21 | 1992-11-04 | Duphar International Research B.V | New pharmaceutical compositions having a psychotropic activity |
AU605304B2 (en) * | 1987-06-22 | 1991-01-10 | Nihon Tokushu Nayaku Seizo K.K. | Benzo-fused cyclic compounds |
FR2667068B1 (fr) * | 1990-09-26 | 1994-09-09 | Adir | Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
US5955470A (en) * | 1991-06-11 | 1999-09-21 | Merrell Pharmaceuticals, Inc. | Derivatives of amide analogs of certain methano bridged quinolizines |
HU227454B1 (en) | 1996-03-29 | 2011-06-28 | Duphar Int Res | Piperazine and piperidine compounds, process for their preparation and pharmaceutical compositions containing the same |
DE69819266T2 (de) | 1997-09-02 | 2004-07-29 | Duphar International Research B.V. | Piperidin- und Piperazin Derivate als 5-HT1-Rezeptor-Agonisten |
AU772189B2 (en) * | 1999-08-23 | 2004-04-08 | Solvay Pharmaceuticals B.V. | New phenylpiperazines |
US20020013314A1 (en) | 2000-02-01 | 2002-01-31 | Bing-Yan Zhu | 3,4-dihydro-2H-benzo[1,4]oxazine inhibitors of factor Xa |
EP1268452A1 (en) | 2000-03-24 | 2003-01-02 | Millenium Pharmaceuticals, Inc. | BICYCLIC SULFONYL AMINO INHIBITORS OF FACTOR Xa |
DE10031391A1 (de) | 2000-07-03 | 2002-02-07 | Knoll Ag | Bicyclische Verbindungen und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie |
HUP0301458A2 (hu) * | 2000-10-26 | 2003-10-28 | Smithkline Beecham Plc. | Benzoxazinonszármazékok, eljárás előállításukra és a vegyületek felhasználása |
ES2316619T3 (es) * | 2001-08-10 | 2009-04-16 | F. Hoffmann-La Roche Ag | Derivados de arilsulfonilo con afinidad receptora de 5-ht 6. |
UA76877C2 (uk) * | 2002-05-13 | 2006-09-15 | Ф.Хоффманн-Ля Рош Аг | Похідні бензоксазину як 5-нт6 модулятори і їх застосування |
-
2003
- 2003-11-04 RU RU2005117965/04A patent/RU2328490C2/ru not_active IP Right Cessation
- 2003-11-04 BR BR0315302-9A patent/BR0315302A/pt not_active Application Discontinuation
- 2003-11-04 JP JP2004549101A patent/JP4401297B2/ja not_active Expired - Fee Related
- 2003-11-04 AT AT03789002T patent/ATE384054T1/de active
- 2003-11-04 ES ES03789002T patent/ES2298609T3/es not_active Expired - Lifetime
- 2003-11-04 EP EP03789002A patent/EP1562918B1/en not_active Expired - Lifetime
- 2003-11-04 CN CNB2003801053862A patent/CN100390157C/zh not_active Expired - Fee Related
- 2003-11-04 DE DE60318733T patent/DE60318733T2/de not_active Expired - Lifetime
- 2003-11-04 KR KR1020057008044A patent/KR100683361B1/ko not_active IP Right Cessation
- 2003-11-04 MX MXPA05004758A patent/MXPA05004758A/es active IP Right Grant
- 2003-11-04 NZ NZ539508A patent/NZ539508A/en not_active IP Right Cessation
- 2003-11-04 AU AU2003293653A patent/AU2003293653B2/en not_active Ceased
- 2003-11-04 TW TW092130842A patent/TWI285639B/zh active
- 2003-11-04 WO PCT/EP2003/012278 patent/WO2004041792A1/en active IP Right Grant
- 2003-11-04 PL PL377770A patent/PL377770A1/pl unknown
- 2003-11-04 CA CA002505334A patent/CA2505334A1/en not_active Abandoned
- 2003-11-04 DK DK03789002T patent/DK1562918T3/da active
- 2003-11-04 PT PT03789002T patent/PT1562918E/pt unknown
- 2003-11-05 PA PA20038587501A patent/PA8587501A1/es unknown
- 2003-11-05 PE PE2003001114A patent/PE20040828A1/es not_active Application Discontinuation
- 2003-11-06 GT GT200300241A patent/GT200300241A/es unknown
- 2003-11-06 US US10/702,302 patent/US7141562B2/en not_active Expired - Fee Related
- 2003-11-07 AR ARP030104100A patent/AR042002A1/es unknown
- 2003-11-07 MY MYPI20034282A patent/MY136824A/en unknown
-
2005
- 2005-04-21 ZA ZA200503248A patent/ZA200503248B/en unknown
- 2005-04-27 NO NO20052074A patent/NO20052074L/no not_active Application Discontinuation
- 2005-05-02 HR HR20050390A patent/HRP20050390A2/xx not_active Application Discontinuation
- 2005-05-02 IL IL168343A patent/IL168343A/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2018009I2 (el) | Παραλλαγες ανοσοσφαιρινων και χρησεις αυτων | |
NO20055568D0 (no) | Substituerte 1,4-diazepiner og anvendelser derav | |
DE60326611D1 (de) | N und dergleichen | |
NO20053974D0 (no) | Tienopyrimidinforbindelser og anvendelse derav. | |
NO20054135D0 (no) | Kipolinon/benzoksazin derivater og anvendelser derav | |
DE60328206D1 (de) | Scheibenwaschanlagendüse und scheibenwaschanlage | |
NO20054095D0 (no) | Pyridyloksymetyl og benzioksazolazabicyklisk derivater | |
DK1562918T3 (da) | Substituerede benzoxazinoner og anvendelser deraf | |
DK1554250T3 (da) | Hidtil ukendt lactamer og anvendelser deraf | |
DE50307654D1 (de) | Vormischbrenner | |
ATE423117T1 (de) | Heterocyclische 7-aminoalkylidenylchinolone und - naphthyridone | |
DE60330269D1 (de) | Piperazinyl- und diazapanylbenzamide und-benzothioamide | |
IS7783A (is) | Flóð og fjöru-ker | |
DK1601744T3 (da) | Forgasningsapparat og fremgangsmåde | |
IS8489A (is) | Umritunarstillar og aðferðir þeirra | |
DE60318139D1 (de) | Isolator- und Anordnungskonfiguration | |
DE60221576D1 (de) | Lötlegierung und lötverbindung | |
IS7694A (is) | Sterasamrunaefnasambönd, framleiðsla og notkun þeirra | |
NO20030347D0 (no) | Antenneelement og gruppeantenne | |
DE602004029488D1 (de) | Leuchtstoffschirm und abbildungsbaugruppe | |
DK1408059T3 (da) | Latex og fremstilling heraf | |
ATA4032002A (de) | Fahnenmast | |
DK1680134T3 (da) | Sammensætninger og anvendelser deraf | |
NO20053898D0 (no) | Use and proceeding at footballshoes | |
DE60219418T8 (de) | Silanylphenole und -naphthole |